1,912
Views
83
CrossRef citations to date
0
Altmetric
Review

The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases

ORCID Icon, &
Pages 291-304 | Received 14 May 2016, Accepted 03 Jan 2017, Published online: 12 Jan 2017

References

  • Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol. 2010;10:365–376. Epub 2010/04/24.
  • Beck IM, Vanden Berghe W, Vermeulen L, et al. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev. 2009;30:830–882. Epub 2009/11/06.
  • Standiford TJ, Kunkel SL, Basha MA, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest. 1990;86:1945–1953. Epub 1990/12/01.
  • Polito AJ, Proud D. Epithelia cells as regulators of airway inflammation. J Allergy Clin Immunol. 1998;102:714–718. Epub 1998/12/29.
  • Ritchlin C. Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res. 2000;2:356–360. Epub 2000/11/30.
  • Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109 Suppl:S81–96. Epub 2002/05/02.
  • Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132:344–362. Epub 2008/02/13.
  • O’Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev. 2008;226:10–18. Epub 2009/01/24.
  • Verstrepen L, Bekaert T, Chau TL, et al. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci. 2008;65:2964–2978. Epub 2008/06/07.
  • Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 1999;18:6867–6874. Epub 1999/12/22.
  • Wagner EF, Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 2005;208:126–140. Epub 2005/11/30.
  • Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1:a000034. Epub 2010/01/13.
  • Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224. Epub 2004/09/17.
  • DiDonato J, Mercurio F, Rosette C, et al. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol. 1996;16:1295–1304. Epub 1996/04/01.
  • Rodriguez MS, Wright J, Thompson J, et al. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene. 1996;12:2425–2435. Epub 1996/06/06.
  • Roff M, Thompson J, Rodriguez MS, et al. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo. J Biol Chem. 1996;271:7844–7850. Epub 1996/03/29.
  • DiDonato JA, Hayakawa M, Rothwarf DM, et al. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997;388:548–554. Epub 1997/08/07.
  • Mercurio F, Zhu H, Murray BW, et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 1997;278:860–866. Epub 1997/11/05.
  • Zandi E, Rothwarf DM, Delhase M, et al. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997;91:243–252. Epub 1997/11/05.
  • Tanaka K, Kawakami T, Tateishi K, et al. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Biochimie. 2001;83:351–356. Epub 2001/04/11.
  • Tokunaga F, Sakata S, Saeki Y, et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol. 2009;11:123–132. Epub 2009/01/13.
  • Chen LF, Williams SA, Mu Y, et al. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol. 2005;25:7966–7975. Epub 2005/09/02.
  • Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene. 2006;25:6717–6730. Epub 2006/10/31.
  • Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. Embo J. 2002;21:6539–6548. Epub 2002/11/29.
  • Kiernan R, Bres V, Ng RW, et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem. 2003;278:2758–2766. Epub 2002/11/07.
  • Mabb AM, Miyamoto S. SUMO and NF-kappaB ties. Cell Mol Life Sci. 2007;64:1979–1996. Epub 2007/05/29.
  • Neumann M, Naumann M. Beyond IkappaBs: alternative regulation of NF-kappaB activity. Faseb J. 2007;21:2642–2654. Epub 2007/04/14.
  • Zenz R, Eferl R, Scheinecker C, et al. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 2008;10:201. Epub 2008/01/30.
  • Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci. 2004;117:5965–5973. Epub 2004/11/27.
  • Eychene A, Rocques N, Pouponnot C. A new MAFia in cancer. Nat Rev Cancer. 2008;8:683–693. Epub 2009/01/15.
  • Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131–6. Epub 2002/05/04.
  • Van Dam H, Castellazzi M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene. 2001;20:2453–2464. Epub 2001/06/13.
  • Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835–839. Epub 1995/12/15.
  • Giguere V. Orphan nuclear receptors: from gene to function. Endocr Rev. 1999;20:689–725. Epub 1999/10/26.
  • Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81:1269–1304. Epub 2001/06/28.
  • Pascual G, Glass CK. Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol Metab. 2006;17:321–327. Epub 2006/09/01.
  • Kurakula K, Koenis DS, Van Tiel CM, et al. NR4A nuclear receptors are orphans but not lonesome. Biochim Biophys Acta. 2014;1843:2543–2555. Epub 2014/07/01.
  • Saijo K, Winner B, Carson CT, et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 2009;137:47–59. Epub 2009/04/07.
  • Hong CY, Park JH, Ahn RS, et al. Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol. 2004;24:2593–2604. Epub 2004/03/17.
  • Harant H, Lindley IJ. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB. Nucleic Acids Res. 2004;32:5280–5290. Epub 2004/10/07
  • Calvayrac O, Rodriguez-Calvo R, Marti-Pamies I, et al. NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFkappaB activation. J Mol Cell Cardiol. 2015;80:34–44. Epub 2014/12/24.
  • Chawla A, Repa JJ, Evans RM, et al. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001;294:1866–1870. Epub 2001/12/01.
  • Martinez-Gonzalez J, Badimon L. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. 2 Cardiovascular Research. 2005;65:609–618. Epub 2005/01/25.
  • Pols TW, Bonta PI, De Vries CJ. NR4A nuclear orphan receptors: protective in vascular disease? Curr Opin Lipidol. 2007;18:515–520. Epub 2007/09/22.
  • Milbrandt J. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron. 1988;1:183–188. Epub 1988/05/01.
  • Law SW, Conneely OM, DeMayo FJ, et al. Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol. 1992;6:2129–2135. Epub 1992/12/01.
  • Ohkura N, Hijikuro M, Yamamoto A, et al. Molecular cloning of a novel thyroid/steroid receptor superfamily gene from cultured rat neuronal cells. Biochem Biophys Res Commun. 1994;205:1959–1965. Epub 1994/12/30.
  • Maruyama K, Tsukada T, Ohkura N, et al. The NGFI-B subfamily of the nuclear receptor superfamily (review). Int J Oncol. 1998;12:1237–1243. Epub 1998/06/04.
  • Wang Z, Benoit G, Liu J, et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature. 2003;423:555–560. Epub 2003/05/30.
  • Baker KD, Shewchuk LM, Kozlova T, et al. The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway. Cell. 2003;113:731–742. Epub 2003/06/18.
  • Wansa KD, Harris JM, Muscat GE. The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J Biol Chem. 2002;277:33001–33011. Epub 2002/06/26.
  • Wansa KD, Harris JM, Yan G, et al. The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J Biol Chem. 2003;278:24776–24790. Epub 2003/04/24.
  • Codina A, Benoit G, Gooch JT, et al. Identification of a novel co-regulator interaction surface on the ligand binding domain of Nurr1 using NMR footprinting. J Biol Chem. 2004;279:53338–53345. Epub 2004/10/01.
  • Safe S, Jin UH, Morpurgo B, et al. Nuclear receptor 4A (NR4A) family – orphans no more. J Steroid Biochem Mol Biol. 2015;157:48–60. Epub 2015/04/29.
  • Pekarsky Y, Hallas C, Palamarchuk A, et al. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc Natl Acad Sci U S A. 2001;98:3690–3694. Epub 2001/03/29.
  • Masuyama N, Oishi K, Mori Y, et al. Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J Biol Chem. 2001;276:32799–32805. Epub 2001/07/05.
  • Galleguillos D, Vecchiola A, Fuentealba JA, et al. PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J Biol Chem. 2004;279:2005–2011. Epub 2003/10/16.
  • Zhao Y, Bruemmer D. NR4A orphan nuclear receptors in cardiovascular biology. Drug Discov Today Dis Mech. 2009;6:e43–e8. Epub 2009/01/01.
  • Wilson TE, Fahrner TJ, Johnston M, et al. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science. 1991;252:1296–1300. Epub 1991/05/31.
  • Philips A, Lesage S, Gingras R, et al. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol. 1997;17:5946–5951. Epub 1997/10/07.
  • Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 1995;9:769–782. Epub 1995/04/01.
  • Zetterstrom RH, Solomin L, Mitsiadis T, et al. Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol Endocrinol. 1996;10:1656–1666. Epub 1996/12/01.
  • Maxwell MA, Muscat GE. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal. 2006;4:e002. Epub 2006/04/11.
  • Kagaya S, Ohkura N, Tsukada T, et al. Prostaglandin A2 acts as a transactivator for NOR1 (NR4A3) within the nuclear receptor superfamily. Biol Pharm Bull. 2005;28:1603–1607. Epub 2005/09/06.
  • Ordentlich P, Yan Y, Zhou S, et al. Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr1. J Biol Chem. 2003;278:24791–24799. Epub 2003/04/24.
  • Pearen MA, Muscat GE. Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol. 2010;24:1891–1903. Epub 2010/04/16.
  • Liu JJ, Zeng HN, Zhang LR, et al. A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res. 2010;70:3628–3637. Epub 2010/04/15.
  • Zhan YY, Chen Y, Zhang Q, et al. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nat Chem Biol. 2012;8:897–904. Epub 2012/09/18.
  • Zhan Y, Du X, Chen H, et al. Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol. 2008;4:548–556. Epub 2008/08/12.
  • Wang WJ, Wang Y, Chen HZ, et al. Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway. Nat Chem Biol. 2014;10:133–140. Epub 2013/12/10.
  • De Waard V, Arkenbout EK, Vos M, et al. TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Pathol. 2006;168:2027–2035. Epub 2006/05/26.
  • Hu YW, Zhang P, Yang JY, et al. Nur77 decreases atherosclerosis progression in apoE(-/-) mice fed a high-fat/high-cholesterol diet. Plos One. 2014;9:e87313. Epub 2014/02/06.
  • Lee SO, Li X, Hedrick E, et al. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells. Mol Endocrinol. 2014;28:1729–1739. Epub 2014/08/08.
  • Inamoto T, Papineni S, Chintharlapalli S, et al. 1,1-Bis(3ʹ-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth. Mol Cancer Ther. 2008;7:3825–3833. Epub 2008/12/17.
  • Safe S, Jin UH, Hedrick E, et al. Minireview: role of orphan nuclear receptors in cancer and potential as drug targets. Mol Endocrinol. 2014;28:157–172. Epub 2013/12/04.
  • Kolluri SK, Zhu X, Zhou X, et al. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell. 2008;14:285–298. Epub 2008/10/07.
  • Ferlini C, Cicchillitti L, Raspaglio G, et al. Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res. 2009;69:6906–6914. Epub 2009/08/13.
  • Watanabe T, Sekine S, Naguro I, et al. Apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway-dependent cytoplasmic translocation of the orphan nuclear receptor NR4A2 is required for oxidative stress-induced necrosis. J Biol Chem. 2015;290:10791–10803. Epub 2015/03/11.
  • Lee SO, Andey T, Jin UH, et al. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53. Oncogene. 2012;31:3265–3276. Epub 2011/11/15.
  • Lee SO, Abdelrahim M, Yoon K, et al. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res. 2010;70:6824–6836. Epub 2010/07/28.
  • Hedrick E, Lee SO, Doddapaneni R, et al. NR4A1 antagonists inhibit beta1-integrin-dependent breast cancer cell migration. Mol Cell Biol. 2016;36:1383–1394. Epub 2016/03/02.
  • Lee SO, Jin UH, Kang JH, et al. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Mol Cancer Res. 2014;12:527–538. Epub 2014/02/12.
  • Hawk JD, Abel T. The role of NR4A transcription factors in memory formation. Brain Res Bull. 2011;85:21–29. Epub 2011/02/15.
  • Hawk JD, Bookout AL, Poplawski SG, et al. NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. J Clin Invest. 2012;122:3593–3602. Epub 2012/09/22.
  • McNulty SE, Barrett RM, Vogel-Ciernia A, et al. Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory. Learn Mem. 2012;19:588–592. Epub 2012/11/20.
  • Mahmoudi S, Samadi P, Gilbert F, et al. Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid. Neurobiol Dis. 2009;36:213–222. Epub 2009/07/29.
  • Volakakis N, Kadkhodaei B, Joodmardi E, et al. NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection. Proc Natl Acad Sci U S A. 2010;107:12317–12322. Epub 2010/06/23.
  • Colon-Cesario WI, Martinez-Montemayor MM, Morales S, et al. Pena de Ortiz S. Knockdown of Nurr1 in the rat hippocampus: implications to spatial discrimination learning and memory. Learn Mem. 2006;13:734–744. Epub 2006/12/05.
  • Eells JB, Wilcots J, Sisk S, et al. NR4A gene expression is dynamically regulated in the ventral tegmental area dopamine neurons and is related to expression of dopamine neurotransmission genes. J Mol Neurosci. 2012;46:545–553. Epub 2011/09/21.
  • Xiang B, Wang W, Li W, et al. Differential expression of oxidored nitro domain containing protein 1 (NOR1), in mouse tissues and in normal and cancerous human tissues. Gene. 2012;493:18–26. Epub 2011/12/14.
  • Levesque D, Rouillard C. Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation. Trends Neurosci. 2007;30:22–30. Epub 2006/12/01.
  • St-Hilaire M, Bourhis E, Levesque D, et al. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice. Eur J Neurosci. 2006;24:795–805. Epub 2006/08/26.
  • Mount MP, Zhang Y, Amini M, et al. Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J Biol Chem. 2013;288:14362–14371. Epub 2013/03/29.
  • Mahmoudi S, Blanchet PJ, Levesque D. Haloperidol-induced striatal Nur77 expression in a non-human primate model of tardive dyskinesia. Eur J Neurosci. 2013;38:2192–2198. Epub 2013/04/05.
  • Xiao G, Sun T, Songming C, et al. NR4A1 enhances neural survival following oxygen and glucose deprivation: an in vitro study. J Neurol Sci. 2013;330:78–84. Epub 2013/05/15.
  • De Miranda BR, Popichak KA, Hammond SL, et al. The Nurr1 activator 1,1-Bis(3ʹ-indolyl)-1-(p-chlorophenyl)methane blocks inflammatory gene expression in BV-2 microglial cells by inhibiting nuclear factor kappaB. Mol Pharmacol. 2015;87:1021–1034. Epub 2015/04/11.
  • Hammond SL, Safe S, Tjalkens RB. A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro. Neurosci Lett. 2015;607:83–89. Epub 2015/09/19.
  • Schaffer DJ, Tunc-Ozcan E, Shukla PK, et al. Nuclear orphan receptor Nor-1 contributes to depressive behavior in the Wistar-Kyoto rat model of depression. Brain Res. 2010;1362:32–39. Epub 2010/09/21.
  • Novak G, Zai CC, Mirkhani M, et al. Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder. Genes Brain Behav. 2010;9:910–917. Epub 2010/07/28.
  • De Miranda BR, Popichak KA, Hammond SL, et al. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson’s disease. Toxicol Sci. 2015;143:360–373. Epub 2014/11/20.
  • Tjalkens RB, Liu X, Mohl B, et al. The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3ʹ-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells. J Neurosci Res. 2008;86:618–629. Epub 2007/11/28.
  • Carbone DL, Popichak KA, Moreno JA, et al. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis. Mol Pharmacol. 2009;75:35–43. Epub 2008/10/09.
  • Pei L, Waki H, Vaitheesvaran B, et al. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med. 2006;12:1048–1055. Epub 2006/08/15.
  • Oita RC, Mazzatti DJ, Lim FL, et al. Whole-genome microarray analysis identifies up-regulation of Nr4a nuclear receptors in muscle and liver from diet-restricted rats. Mech Ageing Dev. 2009;130:240–247. Epub 2009/01/20.
  • Chao LC, Wroblewski K, Zhang Z, et al. Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes. 2009;58:2788–2796. Epub 2009/09/11.
  • Kim YD, Kim SG, Hwang SL, et al. B-cell translocation gene 2 regulates hepatic glucose homeostasis via induction of orphan nuclear receptor Nur77 in diabetic mouse model. Diabetes. 2014;63:1870–1880. Epub 2014/03/22.
  • Bonta PI, Pols TW, De Vries CJ. NR4A nuclear receptors in atherosclerosis and vein-graft disease. Trends Cardiovasc Med. 2007;17:105–111. Epub 2007/04/10.
  • Ranhotra HS. The NR4A orphan nuclear receptors: mediators in metabolism and diseases. J Recept Signal Transduct Res. 2015;35:184–188. Epub 2014/08/05.
  • Arkenbout EK, De Waard V, Van Bragt M, et al. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation. 2002;106:1530–1535. Epub 2002/09/18.
  • Pires NM, Pols TW, De Vries MR, et al. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation. 2007;115:493–500. Epub 2007/01/24.
  • Kim HJ, Kim JY, Lee SJ, et al. alpha-Lipoic acid prevents neointimal hyperplasia via induction of p38 mitogen-activated protein kinase/Nur77-mediated apoptosis of vascular smooth muscle cells and accelerates postinjury reendothelialization. Arterioscler Thromb Vasc Biol. 2010;30:2164–2172. Epub 2010/09/11.
  • Liu D, Jia H, Holmes DI, et al. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol. 2003;23:2002–2007. Epub 2003/10/04.
  • You B, Jiang YY, Chen S, et al. The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of IkappaBalpha expression. Circ Res. 2009;104:742–749. Epub 2009/02/14.
  • Zeng H, Qin L, Zhao D, et al. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med. 2006;203:719–729. Epub 2006/03/08.
  • Bonta PI, Matlung HL, Vos M, et al. Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels. Cardiovasc Res. 2010;87:561–568. Epub 2010/03/02.
  • Hanna RN, Shaked I, Hubbeling HG, et al. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res. 2012;110:416–427. Epub 2011/12/24.
  • Yan G, Zhu N, Huang S, et al. Orphan nuclear receptor Nur77 inhibits cardiac hypertrophic response to beta-adrenergic stimulation. Mol Cell Biol. 2015;35:3312–3323. Epub 2015/07/22.
  • Bonta PI, Pols TW, Van Tiel CM, et al. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation. Circulation. 2010;121:2023–2032. Epub 2010/04/28.
  • Bonta PI, Van Tiel CM, Vos M, et al. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 2006;26:2288–2294. Epub 2006/07/29.
  • Hamers AA, Hanna RN, Nowyhed H, et al. NR4A nuclear receptors in immunity and atherosclerosis. Curr Opin Lipidol. 2013;24:381–385. Epub 2013/09/06.
  • Rodriguez-Calvo R, Guadall A, Calvayrac O, et al. Over-expression of neuron-derived orphan receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury. Hum Mol Genet. 2013;22:1949–1959. Epub 2013/02/08.
  • Rodriguez-Calvo R, Guadall A, Calvayrac O, et al. [The nuclear receptor NOR-1 regulates the activation of vascular cells and vascular remodelling in response to hemodynamic stress]. Clin Investig Arterioscler. 2014;26:66–75. Epub 2014/03/19.
  • Martinez-Gonzalez J, Rius J, Castello A, et al. Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ Res. 2003;92:96–103. Epub 2003/01/11.
  • Rius J, Martinez-Gonzalez J, Crespo J, et al. NOR-1 is involved in VEGF-induced endothelial cell growth. Atherosclerosis. 2006;184:276–282. Epub 2005/06/14.
  • Zhao Y, Howatt DA, Gizard F, et al. Deficiency of the NR4A orphan nuclear receptor NOR1 decreases monocyte adhesion and atherosclerosis. Circ Res. 2010;107:501–511. Epub 2010/06/19.
  • Sekiya T, Kashiwagi I, Yoshida R, et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol. 2013;14:230–237. Epub 2013/01/22.
  • Fassett MS, Jiang W, D’Alise AM, et al. Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proc Natl Acad Sci U S A. 2012;109:3891–3896. Epub 2012/02/22.
  • Nowyhed HN, Huynh TR, Blatchley A, et al. The nuclear receptor nr4a1 controls CD8 T cell development through transcriptional suppression of runx3. Sci Rep. 2015;5:9059. Epub 2015/03/13.
  • Hanna RN, Carlin LM, Hubbeling HG, et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat Immunol. 2011;12:778–785. Epub 2011/07/05.
  • Hilgendorf I, Gerhardt LM, Tan TC, et al. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res. 2014;114:1611–1622. Epub 2014/03/15.
  • Hamers AA, Vos M, Rassam F, et al. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ Res. 2012;110:428–438. Epub 2011/12/24.
  • Mahajan S, Saini A, Chandra V, et al. Nuclear receptor Nr4a2 promotes alternative polarization of macrophages and confers protection in sepsis. J Biol Chem. 2015;290:18304–18314. Epub 2015/05/09.
  • Pei L, Castrillo A, Chen M, et al. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem. 2005;280:29256–29262. Epub 2005/06/21.
  • Pei L, Castrillo A, Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol. 2006;20:786–794. Epub 2005/12/13.
  • Holla VR, Mann JR, Shi Q, et al. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006;281:2676–2682. Epub 2005/11/19.
  • O’Kane M, Markham T, McEvoy AN, et al. Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-alpha inhibition. J Invest Dermatol. 2008;128:300–310. Epub 2007/08/03.
  • Doi Y, Oki S, Ozawa T, et al. Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc Natl Acad Sci U S A. 2008;105:8381–8386. Epub 2008/06/14.
  • Murphy EP, McEvoy A, Conneely OM, et al. Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis. Arthritis Rheum. 2001;44:782–793. Epub 2001/04/24.
  • Aherne CM, McMorrow J, Kane D, et al. Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. Mol Immunol. 2009;46:3345–3357. Epub 2009/09/08.
  • Shao Q, Shen LH, Hu LH, et al. He B. Nuclear receptor Nur77 suppresses inflammatory response dependent on COX-2 in macrophages induced by oxLDL. J Mol Cell Cardiol. 2010;49:304–311. Epub 2010/04/13.
  • Diatchenko L, Romanov S, Malinina I, et al. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes. J Leukoc Biol. 2005;78:1366–1377. Epub 2005/10/06.
  • Li L, Liu Y, Chen HZ, et al. Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation. Nat Chem Biol. 2015;11:339–346. Epub 2015/03/31.
  • Li XM, Zhang S, He XS, et al. Nur77-mediated TRAF6 signalling protects against LPS-induced sepsis in mice. J Inflamm (Lond). 2016;13:4. Epub 2016/02/04.
  • Ipseiz N, Uderhardt S, Scholtysek C, et al. The nuclear receptor Nr4a1 mediates anti-inflammatory effects of apoptotic cells. J Immunol. 2014;192:4852–4858. Epub 2014/04/18.
  • Zhang X, Yan G, Diao Z, et al. NUR77 inhibits the expression of TIMP2 and increases the migration and invasion of HTR-8/SVneo cells induced by CYR61. Placenta. 2012;33:561–567. Epub 2012/05/04.
  • Gruber F, Hufnagl P, Hofer-Warbinek R, et al. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression. Blood. 2003;101:3042–3048. Epub 2002/12/31.
  • Rodriguez-Calvo R, Ferran B, Alonso J, et al. NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells. Thromb Haemost. 2015;113:1323–1334. Epub 2015/03/27.
  • Zhao Y, Liu Y, Zheng D. Alpha 1-antichymotrypsin/SerpinA3 is a novel target of orphan nuclear receptor Nur77. Febs J. 2008;275:1025–1038. Epub 2008/02/06.
  • Crean D, Cummins EP, Bahar B, et al. Adenosine modulates NR4A orphan nuclear receptors to attenuate hyperinflammatory responses in monocytic cells. J Immunol. 2015;195:1436–1448. Epub 2015/07/08.
  • Raveney BJ, Oki S, Yamamura T. Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling. Plos One. 2013;8:e56595. Epub 2013/02/26.
  • Mix KS, Attur MG, Al-Mussawir H, et al. Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. J Biol Chem. 2007;282:9492–9504. Epub 2007/02/07.
  • Mix KS, McMahon K, McMorrow JP, et al. Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription. Arthritis Rheum. 2012;64:2126–2136. Epub 2012/01/26.
  • Wu Y, Ghosh S, Nishi Y, et al. The orphan nuclear receptors NURR1 and NGFI-B modulate aromatase gene expression in ovarian granulosa cells: a possible mechanism for repression of aromatase expression upon luteinizing hormone surge. Endocrinology. 2005;146:237–246. Epub 2004/10/16.
  • Lammi J, Huppunen J, Aarnisalo P. Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol Endocrinol. 2004;18:1546–1557. Epub 2004/02/28.
  • Attur MG, Dave MN, Stuchin S, et al. Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum. 2001;44:578–584. Epub 2001/03/27.
  • McCoy JM, Walkenhorst DE, McCauley KS, et al. Orphan nuclear receptor NR4A2 induces transcription of the immunomodulatory peptide hormone prolactin. J Inflamm (Lond). 2015;12:13. Epub 2015/02/27.
  • Chen P, Li J, Huo Y, et al. Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis. PeerJ. 2015;3:e1518. Epub 2015/12/30.
  • Nomiyama T, Zhao Y, Gizard F, et al. Deficiency of the NR4A neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury. Circulation. 2009;119:577–586. Epub 2009/01/21.
  • Adya R, Tan BK, Chen J, et al. Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation. Diabetes Care. 2008;31:758–760. Epub 2008/01/11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.